0001415889-24-011870.txt : 20240501
0001415889-24-011870.hdr.sgml : 20240501
20240501163013
ACCESSION NUMBER: 0001415889-24-011870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240429
FILED AS OF DATE: 20240501
DATE AS OF CHANGE: 20240501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 24903495
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-05012024_040501.xml
X0508
4
2024-04-29
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1000 SPRING STREET
SILVER SPRING
MD
20910
true
true
false
false
CHAIRPERSON & CEO
1
Common Stock
2024-04-29
4
M
0
3600
129.49
A
3730
D
Common Stock
2024-04-29
4
S
0
35
234.76
D
3695
D
Common Stock
2024-04-29
4
S
0
278
236.8375
D
3417
D
Common Stock
2024-04-29
4
S
0
596
237.7018
D
2821
D
Common Stock
2024-04-29
4
S
0
1706
238.5588
D
1115
D
Common Stock
2024-04-29
4
S
0
732
239.7822
D
383
D
Common Stock
2024-04-29
4
S
0
253
240.5483
D
130
D
Common Stock
2024-04-30
4
M
0
3600
129.49
A
3730
D
Common Stock
2024-04-30
4
S
0
1000
234.712
D
2730
D
Common Stock
2024-04-30
4
S
0
2349
235.5198
D
381
D
Common Stock
2024-04-30
4
S
0
251
236.3717
D
130
D
Stock Options
129.49
2024-04-29
4
M
0
3600
0
D
2014-12-31
2024-12-31
Common Stock
3600
291869
D
Stock Options
129.49
2024-04-30
4
M
0
3600
0
D
2014-12-31
2024-12-31
Common Stock
3600
288269
D
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
This transaction was executed in multiple trades at prices ranging from $236.065 to $237.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $237.135 to $238.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $238.15 to $239.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $239.28 to $240.195. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $240.28 to $240.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $234.04 to $235.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $235.045 to $236.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $236.115 to $236.605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2024-05-01